Mitchell Cancer Institute, University of South Alabama, United States.
Department of Biological Sciences, University of Southern Mississippi Gulf Coast, United States.
Cancer Lett. 2014 Mar 28;344(2):166-73. doi: 10.1016/j.canlet.2013.11.004. Epub 2013 Nov 19.
MicroRNAs (miRNAs) are a set of non-coding small RNA molecules in control of gene expression at posttranscriptional/translational level. They not only play crucial roles in normal developmental progress, but also are commonly dysregulated in human diseases, including cancer. MiR-200 is a family of tumor suppressor miRNAs consisting of five members, which are significantly involved in inhibition of epithelial-to-mesenchymal transition (EMT), repression of cancer stem cells (CSCs) self-renewal and differentiation, modulation of cell division and apoptosis, and reversal of chemoresistance. In this article, we summarize the latest findings with regard to the tumor suppressor signatures of miR-200 and the regulatory mechanisms of miR-200 expression. The collected evidence supports that miR-200 is becoming a new star miRNA in study of human cancer.
MicroRNAs (miRNAs) 是一组非编码的小 RNA 分子,在转录后/翻译水平控制基因表达。它们不仅在正常发育过程中起着至关重要的作用,而且在包括癌症在内的人类疾病中通常失调。miR-200 是一组肿瘤抑制 miRNA,由五个成员组成,它们显著参与抑制上皮-间充质转化 (EMT)、抑制癌症干细胞 (CSC) 的自我更新和分化、调节细胞分裂和凋亡以及逆转化学耐药性。本文总结了 miR-200 的肿瘤抑制特征和 miR-200 表达调控机制的最新发现。收集的证据表明,miR-200 正在成为人类癌症研究的一颗新星 miRNA。